Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

NCT06176716 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Insufficiency

Interventions

DRUG: ET-26

Sponsor

Ahon Pharmaceutical Co., Ltd.